Manufacturer: UCB INC
Date approved: November 30, 1999
Status: Prescription Only
Approved uses: Anticonvulsant used to treat simple and complex partial seizures and myclonic seizures
Off-Label uses: Neuropathic pain, migraines, other seizures not listed above, Landau-Kleffner syndrome, autism and social anxiety.
• Reports of Ineffectiveness of Mylan Keppra (generic)
• Suicide Risk
• Increased Psychotic Episodes
Common Misspellings: Kepra, Levetiracetam
Keppra is an anticonvulsant medication used to treat simple and complex partial seizures and myclonic seizures as well as migraines, autism, social anxiety and neuropathic pain. Keppra has been linked to several serious side effects, including an increase in psychotic episodes and hallucinations.
Recent reports have questioned the effectiveness of generic Keppra (Levetiracetam) manufactured by Mylan Pharmaceuticals. The drug, which was approved for sale in Nov. 2008, has been linked to an increase in seizures, migraines, light headedness and side effects not experience when taking brand name Keppra. Patients who have experienced these serious side effects of generic Kepra after not not experiencing them while taking brand name Keppra may contact a generic Keppra attorney for additional information and a free consult.